ZERBAXA
NDC 67919-030, ceftolozane and tazobactam, injection, powder, lyophilized, for solution, from Merck Sharp & Dohme LLC.
- Product NDC
- 67919-030
- Status
- Listed
- Labeler
- Merck Sharp & Dohme LLC
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA206829
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/67919-030 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CEFTOLOZANE SULFATE1 g/10mL
- TAZOBACTAM SODIUM.5 g/10mL
Pharmacologic classes
Cephalosporin Antibacterial [EPC]; Cephalosporins [CS]; beta Lactamase Inhibitor [EPC]; beta Lactamase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 67919-030-01 | 67919003001 | 10 VIAL, SINGLE-DOSE in 1 CARTON (67919-030-01) / 10 mL in 1 VIAL, SINGLE-DOSE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/70ac1d90-eff3-4f0b-9f46-5846c571b32fMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=67919-030
Use it
Look up 67919-030 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/67919-030 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 67919-030. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.